FDA Grants Priority Review to Iberdomide for Multiple Myeloma - Oncology Nurse Advisor The NDA is supported by data from the EXCALIBER-RRMM trial, which evaluated the safety and efficacy of iberdomide, an investigational cereblon E3 ligase modulator.

@fda.gov grants Priority Review to iberdomide for #RRMM.

• Target: E3 ligase modulator (CELMoD)
• Phase 3 EXCALIBUR results: Improved PFS
• Target action date: May 2026

Insights via @medicalprofref.bsky.social.

Read the review: https://bit.ly/3Olgg0s

#mmsm #MultipleMyeloma #FDA

🩸Facts about Multiple Myeloma:

Bispecific Antibodies (BsAbs) – Mechanism and Approval

#MultipleMyeloma #RRMM #Hematology #HemOnc #BispecificAntibodies #BsAbs #Immunotherapy #CD3 #BCMA #Teclistamab #Elranatamab #Linvoseltamab #MedEd

Client Challenge

A Phase 1 study by Dr. Noffar Bar
@yale-hematology.bsky.social shows subcutaneous alnuctamab #ALNUC is active in #RRMM, with a 58–71% response rate, ~50% of patients achieving MRD negativity, and better safety than IV dosing. #multiplemyeloma
www.nature.com/articles/s41...

Probably the most important data in #myeloma was presented today #ASH25. @_DrCP explains in this video the main results of #majestec3 trial looking at the combination of daratumumab and teclistamab in #RRMM
youtu.be/LEFWII_tnsc?...

FDA Approval of Belantamab - Dana-Farber Cancer Institute's Role in the Drug Development - OncoDaily FDA Approval of Belantamab - Dana-Farber Cancer Institute's Role in the Drug Development / belantamab, belantamab mafodotin, blmf, cancer, Dana-Farber Cancer

FDA Approval of Belantamab - Dana-Farber Cancer Institute’s Role in the Drug Development

@fda.gov @danafarber.bsky.social @danafarbernews.bsky.social

oncodaily.com/community/be...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #MM #RRMM #Myeloma #DanaFarber #Belantamab

BVd Regimen Significantly Improves Survival Compared With DVd in RRMM Researchers determined BVd significantly improved survival compared with DVd for patients with RRMM.

Belantamab mafodotin combined with BVd significantly improved OS compared with DVd in patients with R/R #multipleMyeloma. Published in ‪@thelancetoncol.bsky.social.

https://bit.ly/47LEJU7

#RRMM

#MultipleMyeloma #CAR_T #Talquetamab #RRMM #Oncology #Hematology #CellTherapy #RealWorldEvidence #MyelomaResearch #Immunotherapy #GPRC5D #BCMA

Linvoseltamab (Lynozyfic) 2025 Updates: Uses in Cancer, Dosage, Side Effects, Expectations, and More - OncoDaily Linvoseltamab (Lynozyfic) is anti CD38 mab, which used for relapsed or refractory multiple myeloma. learn about its uses, dose, side effects.

Linvoseltamab (Lynozyfic) 2025 Updates: Uses in Cancer, Dosage, Side Effects, Expectations, and More

oncodaily.com/drugs/linvos...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Linvoseltamab #Lynozyfic #MM #RRMM #Myeloma

Early relapsed/refractory multiple myeloma (RRMM): best practices in management | COR2ED

🚨 Best practices in managing early relapsed/refractory multiple myeloma

3-part video series with expert insights & downloadable slide sets
⬇️
cor2ed.com/lymphoma-mye...

Supported by an Independent Educational Grant from Menarini Stemline Oncology

#MedSky #MedEd #RRMM

EHA 2025 Highlights: JNJ-5322 Trispecific Antibody in RRMM EHA 2025 highlights first-in-human results of JNJ-5322, a trispecific antibody with 100% ORR in naïve RRMM patients and favorable safety profile.

EHA Highlights: First-in-Human Study of Trispecific Antibody JNJ-5322 Shows Promising Activity in Relapsed/Refractory Multiple Myeloma

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EHA #EHA2025 #MM #RRMM

New Research from MD Anderson Shows that Teclistamab is Safe and Effective for Older Patients with RRMM - OncoDaily New Research from MD Anderson Shows that Teclistamab is Safe and Effective for Older Patients with RRMM / cancer, Hans Lee, MD Anderson Cancer Center, MM,

New Research from MD Anderson Shows that Teclistamab is Safe and Effective for Older Patients with RRMM
@mdanderson.bsky.social

oncodaily.com/insight/tecl...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #RRMM #MultipleMyeloma #Teclistamab #MDAnderson

A recent study highlights bispecific antibodies #BsAbs as a powerful bridging therapy before BCMA CAR-T cell treatment for relapsed/refractory multiple myeloma #RRMM

@theaacr.bsky.social #bcd_aacr

#Onco404 #Cancer #Kanser #MultipleMyeloma #CARTCellTherapy #MedSky #Immunotherapy #Hematology

Necesidad de #predectibilidad. Algunas familias suelen esconderle a sus hijos los #RRMM para darle más emoción y que lo valoren más. No lo hagáis con un niño #TCS #CEA " #Asperger" porque para ellos el mayor regalo no es en sí el juguete regalado sino que sus majestades cumplan con la promesa a un +

Addressing Key Questions About BCMA-Targeted Therapy for… freeCME.com provides free continuing medical education for physicians & other medical professionals. Meet requirements online with free CE & free CME…

Attention health care professionals in #myeloma! 📢 In this CME-accredited activity, experts address key questions about BCMA-targeted therapy for #RRMM. Start today before this activity expires NEXT week: www.freecme.com/products/add...

The Force is strong with these "funitas" 🔥 Sizzling steak, peppers 🌶️ onions 🧅 and all the fixings wrapped up in a warm tortilla—Jedi-approved ⚔️✨ Don’t miss back to back episodes of the season finale tonight at 9/8c on FYI 📺

#MayTheForkBeWithYou #RRMM #MealsInMinutes #FreeFoodsStudio #NailedIt

Ide-cel and cilta-cel have revolutionized the treatment of relapsed/refractory multiple myeloma, but direct comparisons are lacking. Utilizing an international multicenter RRMM cohort, authors compare the outcome of ide-cel versus cilta-cel. Read about the findings here 👉https://bit.ly/40CAJ4q
#RRMM

Ostentación

Recuerdo un año más.

No hagamos ostentación y pensemos en quien no tienen.

#reyesmagos #6enero #RM #RRMM

Denuncian maltrato animal durante la visita del Heraldo Real en Granada Uno de los integrantes del cortejo real golpeó el hocico de un buey durante la cabalgata El Heraldo Real cambia cartas por ilusión en su visita a Granada

Este energúmeno le pega un rodillazo a un buey en un desfile con público infantil en #Granada no quiero imaginar qué hará con sus animales de puertas para adentro. Es un delito, es una bestialidad y hay que denunciar y visibilizar.
#MaltratoAnimal #Navidad #RRMM

www.granadahoy.com/granada/denu...

(enero de 2022)
#autismo y #RRMM desde la perspectiva de mi hijo #CEA 7 años. Esta es una de los momentos más mágicos del año y para los ND, más. Lo 1º fue elegir que quería para RRMM y Papa Noel. Podía elegir 3 regalos+1 así que se dedicó a ver revistas y anuncios de tv y en el 10-12 diciembre

Muy buen trabajo de @anaarriba.bsky.social y @hendrix-bcn.bsky.social sobre la cobertura del #IMV y las #RRMM en las diferentes CCAA.